Skip to main content

Table 4 Overall Survival: Univariate and Multivariate Analyses for All Patients (N = 46)

From: Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Patient Characteristic HR on Univariate Analysis (95% confidence interval with p-value) HR on Multivariate Analysis (95% confidence interval with p-value)
Histone acetylation (Positive versus negative 0.45 (0.21-0.96), p = 0.038 0.51 (0.23-1.31), p = 0.09
Age (>35 years vs. ≤35 years) 1.81 (0.84-3.91), p = 0.13 2.41 (0.75-7.74), p = 0.14
White blood count (>20,000/μL versus ≤20,000/μL) 1.87 (0.87-4.03), = 0.11 3.36 (0.90-12.5), p = 0.07
Poor risk CG vs. others 1.95 (0.82-4.68), p = 0.13